Too much haste in US drug approval? (Nature)
The US Food and Drug Administration (FDA) may be issuing shaky last-minute drug approvals, according to a new study.

Proteolix's Carfilzomib Receives Orphan Drug Designation For Treatment Of Multiple Myeloma (Medical News Today)
Proteolix, Inc., a clinical-stage company engaged in the development of novel pharmaceutical therapies for the treatment of cancer and immunological conditions, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to carfilzomib, a selective blocker of proteasome activity for the treatment of multiple myeloma.

Kingfisher Announces FDA 510(k) Clearance Of Breakthrough KFH Energy For Chronic Pain Sufferers (Medical News Today)
Kingfisher Americas, a healthcare company focused on improving patient quality of life, announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market KFH Energy in the United States.